{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:10:19Z","timestamp":1779311419498,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T00:00:00Z","timestamp":1545609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10157-018-1672-1","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T07:54:36Z","timestamp":1545638076000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review"],"prefix":"10.1007","volume":"23","author":[{"name":"the Japan Academic Consortium of Kidney Transplantation (JACK) Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tsuchimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Omoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Okumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Nishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,24]]},"reference":[{"key":"1672_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1053\/ajkd.2000.9787","volume":"36","author":"H Imai","year":"2000","unstructured":"Imai H, Oyama Y, Miura AB, Endoh M. Sakai H. Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis. 2000;36:474\u201380.","journal-title":"Am J Kidney Dis"},{"key":"1672_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/cncr.23773","volume":"113","author":"M Choi","year":"2008","unstructured":"Choi M, Sun CL, Kurian S, et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer. 2008;113:1580\u20137.","journal-title":"Cancer"},{"key":"1672_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/ndt\/gfp485","volume":"25","author":"M Ando","year":"2010","unstructured":"Ando M, Ohashi K, Akiyama H, et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transpl. 2010;25:278\u201382.","journal-title":"Nephrol Dial Transpl"},{"key":"1672_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.1996.14.2.579","volume":"14","author":"R Miralbell","year":"1996","unstructured":"Miralbell R, Bieri S, Mermillod B, et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol. 1996;14:579\u201385.","journal-title":"J Clin Oncol"},{"key":"1672_CR5","first-page":"339","volume":"3","author":"ME Chappell","year":"1988","unstructured":"Chappell ME, Keeling DM, Prentice HG. Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transpl. 1988;3:339\u201347.","journal-title":"Bone Marrow Transpl"},{"key":"1672_CR6","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/1097-0142(19910601)67:11<2795::AID-CNCR2820671114>3.0.CO;2-D","volume":"67","author":"CA Lawton","year":"1991","unstructured":"Lawton CA, Cohen EP, Barber-Derus SW, et al. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer. 1991;67:2795\u2013800.","journal-title":"Cancer"},{"key":"1672_CR7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s00467-002-0989-9","volume":"17","author":"JE Kist-van Holthe","year":"2002","unstructured":"Kist-van Holthe JE, Goedvolk CA, Brand R, et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol. 2002;17:1032\u20137.","journal-title":"Pediatr Nephrol"},{"key":"1672_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1034\/j.1600-6143.2003.00015.x","volume":"3","author":"K Hamawi","year":"2003","unstructured":"Hamawi K, De Magalhaes-Silverman M. Bertolatus JA. Outcomes of renal transplantation following bone marrow transplantation. Am J Transpl. 2003;3:301\u20135.","journal-title":"Am J Transpl"},{"key":"1672_CR9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.7326\/0003-4819-114-11-954","volume":"114","author":"MH Sayegh","year":"1991","unstructured":"Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL. Tilney NL. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med. 1991;114:954\u20135.","journal-title":"Ann Intern Med"},{"key":"1672_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0140-6736(94)91881-3","volume":"343","author":"N Jacobsen","year":"1994","unstructured":"Jacobsen N, Taaning E, Ladefoged J, Kristensen JK. Pedersen FK. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet. 1994;343:800.","journal-title":"Lancet"},{"key":"1672_CR11","first-page":"1420","volume":"58","author":"C Helg","year":"1994","unstructured":"Helg C, Chapuis B, Bolle JF, et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation. 1994;58:1420\u20132.","journal-title":"Transplantation"},{"key":"1672_CR12","first-page":"1633","volume":"59","author":"JM Sorof","year":"1995","unstructured":"Sorof JM, Koerper MA, Portale AA, Potter D, DeSantes K. Cowan M. Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation. Transplantation. 1995;59:1633\u20135.","journal-title":"Transplantation"},{"key":"1672_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1600-6143.2010.03352.x","volume":"11","author":"J Fangmann","year":"2011","unstructured":"Fangmann J, Kathrin Al-Ali H, Sack U, et al. Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transpl. 2011;11:156\u201362.","journal-title":"Am J Transpl"},{"key":"1672_CR14","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1111\/tri.12332","volume":"27","author":"C Garrouste","year":"2014","unstructured":"Garrouste C, Socie G. Heng AE. Kidney transplantation after previous hematopoietic stem cell transplant: need of immunosuppressive treatment? Transpl Int. 2014;27:e92\u20133.","journal-title":"Transpl Int"},{"key":"1672_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1034\/j.1399-0012.1999.130409.x","volume":"13","author":"JA Butcher","year":"1999","unstructured":"Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM. Cohen EP. Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transpl. 1999;13:330\u20135.","journal-title":"Clin Transpl"},{"key":"1672_CR16","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1097\/TP.0000000000000852","volume":"99","author":"J Younge","year":"2015","unstructured":"Younge J, Duffner UA, Bunchman T. Abdel-Mageed A. Ten year follow-up for a patient postmatched unrelated donor bone marrow transplant followed by same donor kidney transplant: normal renal function without immunosuppression. Transplantation 2015;99:e162.","journal-title":"Transplantation"},{"key":"1672_CR17","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1442-2042.2007.01877.x","volume":"14","author":"T Tanaka","year":"2007","unstructured":"Tanaka T, Ishida H, Shirakawa H, Amano H, Nishida H. Tanabe K. Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor. Int J Urol. 2007;14:1044\u20135.","journal-title":"Int J Urol"},{"key":"1672_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","volume":"14","author":"M Haas","year":"2014","unstructured":"Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14:272\u201383.","journal-title":"Am J Transplant"},{"key":"1672_CR19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","volume":"270","author":"FK Port","year":"1993","unstructured":"Port FK, Wolfe RA, Mauger EA, Berling DP. Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993;270:1339\u201343.","journal-title":"JAMA"},{"key":"1672_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0272-6386(12)80160-0","volume":"24","author":"AO Ojo","year":"1994","unstructured":"Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L. Berling DP. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis. 1994;24:59\u201364.","journal-title":"Am J Kidney Dis"},{"key":"1672_CR21","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.V9112135","volume":"9","author":"P Schnuelle","year":"1998","unstructured":"Schnuelle P, Lorenz D, Trede M. Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998;9:2135\u201341.","journal-title":"J Am Soc Nephrol"},{"key":"1672_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725\u201330.","journal-title":"N Engl J Med"},{"key":"1672_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2215\/CJN.08670815","volume":"11","author":"N Goto","year":"2016","unstructured":"Goto N, Okada M, Yamamoto T, et al. Association of dialysis duration with outcomes after transplantation in a Japanese cohort. Clin J Am Soc Nephrol. 2016;11:497\u2013504.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1672_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ki.1993.234","volume":"44","author":"RH Rubin","year":"1993","unstructured":"Rubin RH. Infectious disease complications of renal transplantation. Kidney Int. 1993;44:221\u201336.","journal-title":"Kidney Int"},{"key":"1672_CR25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V133769","volume":"13","author":"HU Meier-Kriesche","year":"2002","unstructured":"Meier-Kriesche HU, Arndorfer JA. Kaplan B. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol. 2002;13:769\u201372.","journal-title":"J Am Soc Nephrol"},{"key":"1672_CR26","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/TP.0000000000001324","volume":"101","author":"K Masutani","year":"2017","unstructured":"Masutani K, Tsuchimoto A, Kurihara K, et al. Histological analysis in ABO-compatible and ABO-incompatible kidney transplantation by performance of 3- and 12-month protocol biopsies. Transplantation 2017;101:1416\u20131422.","journal-title":"Transplantation"},{"key":"1672_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/tri.12081","volume":"26","author":"D Chandrasekharan","year":"2013","unstructured":"Chandrasekharan D, Issa F. Wood KJ. Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions? Transpl Int. 2013;26:576\u201389.","journal-title":"Transpl Int"},{"key":"1672_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJMoa071074","volume":"358","author":"T Kawai","year":"2008","unstructured":"Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358:353\u201361.","journal-title":"N Engl J Med"},{"key":"1672_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa074191","volume":"358","author":"JD Scandling","year":"2008","unstructured":"Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med. 2008;358:362\u20138.","journal-title":"N Engl J Med"},{"key":"1672_CR30","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.transproceed.2011.01.161","volume":"43","author":"AV Vanikar","year":"2011","unstructured":"Vanikar AV, Goplani KR, Feroz A, et al. Operational tolerance in living-related renal transplantation: a single-center experience. Transpl Proc. 2011;43:1551\u20138.","journal-title":"Transpl Proc"},{"key":"1672_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199703273361301","volume":"336","author":"RE Curtis","year":"1997","unstructured":"Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897\u2013904.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1672-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:56:57Z","timestamp":1662685017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1672-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,24]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1672-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,24]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Potential financial conflicts of interest: Astellas Pharma Inc. (Tokyo, Japan) supported this study and Kazunari Tanabe with a grant. The sponsor was not involved in the study design, patient enrolment, data collection, analysis, interpretation, or preparation of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number UMIN000018327) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}